the aid library

LIST OPTIONS

Filter

3417

Sort by:

Direction:

Download (1410)

View PDF (2404)

Screening for Type 2 Diabetes

WHO WHO (2003)

Report of a World Health Organization and International Diabetes Federation meeting

Download (962)

View PDF (2118)

WHO/OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern

WHOOIE (2001)

This Manual covers all important aspects of echinococcosis, including parasite biology and life-cycles, geographic distribution and prevalence, epidemiology, clinical presentation in humans and animals, diagnosis and treatment, as well as control and prevention using newly developed tools and method... more

Download (632)

View PDF (449)

Traitement normalisé de la méningite en Afrique en situation épidémique ou non épidémique

Organisation Mondiale de la Santé (2007) C_WHO

Download (171)

View PDF (329)

Controlled clinical trails in Tuberculosis

A. Jindani, A. Nunn, D. A. Enarson International Union Against Tuberculosis and Lung Disease (2004)

A Guide For Multicentre Trials in High-Burden Countries

Download (124)

View PDF (232)

Child soldiers. The shadow of their existence

War Child (2007) C2

This report outlines the known problems of child soldiers and the different forms of recruiting. The report zooms in on the Colombia situation and the motives with which Colombian children join these armed groups. Finally there's a list of actions that can be taken to change this situation and the c... more

Download (2222)

View PDF (196)

Всемирный доклад о наркотиках 2008

Анджела Ми, Тибо ле Пишон, Коэн Буссинк e tal. Организация Объединенных Наций, UNODC (2009)

Во Всемирном докладе о наркотиках содержится комплексная информация по положению в области незаконных наркотиков. В нем представлены подробные оценки и тенденци�... more

Download (272)

View PDF (306)

Manual for the Public Health Management of Chemical Incidents (English, French and Spanish version)

World Health Organization (2009) C_WHO

The purpose of the WHO Manual for the Public Health Management of Chemical Incidents is to provide a comprehensive overview of the principles and roles of public health in the management of chemical incidents and emergencies. While this information is provided for each phase of the emergency cycle, ... more

Download (350)

View PDF (633)

Ethiopia: National Nutrition and HIV/AIDS Implementation Reference Manual

Federal Ministry of Health, Ethiopia (2008) C1

Download (1195)

View PDF (3515)

Investigating cause of death during an outbreak of Ebola virus haemorrhagic fever: draft verbal autopsy instrument

World Health Organization (2003)

Download (1191)

View PDF (1907)

Containing Hemorrhagic Fever Epidemic, The Ebola Experience in Uganda (October 2000 – January 2001)

Lamunu M, Lutwama J.J, Kamugisha J; et al. (2002)

A paper presented at the 10th International Congress on Infectious Disease, Singapore

Download (125)

View PDF (167)

Mobile Health Units

International Committee of the Red Cross (ICRC) (2006) C2

Download (121)

View PDF (171)

Nutrition Strategic Shift Thin Piece

UN Children's Fund UNICEF (2022) C_UNICEF

UNICEF Syria’s series of think pieces. Every day counts. An outlook on child protection for the most vulnerable children in Syria.To navigate the complex and continuously changing context and attain sustainable results for children, UNICEF – along with other UN agencies - seeks to make a shift i... more

Download (162)

View PDF (190)

Global framework for the response to malaria in urban areas

World Health Organization WHO (2022) C_WHO

Cities are uniquely positioned to understand local needs and respond rapidly to changing conditions to safeguard health. These changes require strong city leadership to implement multisectoral, health-relevant policies and public services that engage communities. The response to malaria must be an i... more

Download (195)

View PDF (210)

WHO's Health Emergency Appeal 2023

World Health Organisation (WHO) (2023) C_WHO

WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r... more

Download (121)

View PDF (225)

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Tanzania

Africa Center for Disease Control and Prevention (2023) CC

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr... more

Download (181)

View PDF (151)

Considerations for developing a national genomic surveillance strategy or action plan for pathogens with pandemic and epidemic potential

World Health Organization WHO (2023) C_WHO

Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant... more

Download (137)

View PDF (121)

Guidance for country validation of viral hepatitis elimination and path to elimination

World Health Organization WHO (2023) C_WHO

Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (18)

View PDF (63)

The missing link: Rethinking and reprioritizing HIV and gender-based violence in fragile settings

UNAIDS (2024) CC

This report explores the extent to which evidence, policy, normative guidance and commitments on HIV and gender-based violence, and their interlinkages, is being translated into action on the ground in fragile settings. These issues are explored through the lens of training of peace support operatio... more

Download (14)

View PDF (11)

The Malawi Noncommunicable Diseases & Injuries Poverty Commission Report

Republic of Malawi; Ministry of Health (2018) CC2

As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that have transformed the global health landscape.